Clinical sighificance of Blood glucose, AFP and cholinesterase levels on the early diagnosis and prognosis of severe hepatitis patients
10.3760/cma.j.issn.1008-6706.2011.02.015
- VernacularTitle:重型肝炎患者血糖、甲胎蛋白和胆碱脂酶检测的临床意义
- Author:
Shiqian WANG
;
Xianhua ZHANG
;
Dejun XU
- Publication Type:Journal Article
- Keywords:
Hepatitis;
Glucose;
Alpha-fetoprotein;
Cholinesterase
- From:
Chinese Journal of Primary Medicine and Pharmacy
2011;18(2):175-176
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study clinical value of blood glucose, AFP and cholinesterase levels on the diagnosis and prognosis of severe hepatitis. Methods Retrospective analysis of chronic hepatitis B, cirrhosis, chronic severe hepatitis, subacute severe hepatitis was carried out. In severe hepatitis patients, between the improved group and death group, blood glucose, AFP, cholinesterase differences, evaluate blood glucose, alpha-fetoprotein, cholinesterase levels on the diagnosis and prognosis of severe hepatitis value were compared. Results Subacute severe hepatitis, chronic severe hepatitis patients and blood cholinesterase levels were significantly lower than that in patients with chronic hepatitis B and liver cirrhosis(all P ＜ 0.05) ;and alpha-fetoprotein level was significantly higher than the level of chronic hepatitis B patients(P ＜ 0. 01) ;improved levels of blood glucose in patients with severe hepatitis, AFP, cholinesterase levels were significantly higher than the level of death group (all P ＜ 0.05). Conclusion Blood glucose, AFP, cholinesterase levels of liver disease progression and prognosis were important to determine the value.
